AN2 Therapeutics, Inc. - ANTX

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Sep 16, 2026 Chief Medical Officer A A 233,333.0 0.0 0.0 233,333.0 View
Sep 16, 2026 Chief Medical Officer A A 116,667.0 0.0 0.0 116,667.0 View
Sep 11, 2026 — S D 585.0 6.0243 3,524.22 624,765.0 View
Sep 11, 2026 — S D 523.0 6.0243 3,150.71 557,467.0 View
Sep 08, 2026 — S D 5,294.0 6.0183 31,860.88 625,350.0 View
Sep 08, 2026 — S D 4,725.0 6.0183 28,436.47 557,990.0 View
Sep 08, 2026 — S D 3,223.0 6.0698 19,562.97 630,644.0 View
Sep 08, 2026 — S D 2,877.0 6.0698 17,462.81 562,715.0 View
Sep 04, 2026 Principal Accounting Officer S D 272.0 5.53 1,504.16 66,311.0 View
Sep 02, 2026 — P A 2,098.0 5.53 11,601.94 10,708.0 View
Aug 19, 2026 — S D 18,706.0 6.0082 112,389.39 633,867.0 View
Aug 19, 2026 — S D 16,696.0 6.0082 100,312.91 565,592.0 View
Aug 14, 2026 — G D 405,880.0 0.0 0.0 0.0 View
Jul 10, 2026 — A A 2,852.0 0.0 0.0 59,106.0 View
Jul 10, 2026 — A A 2,789.0 0.0 0.0 81,873.0 View
Jul 10, 2026 — A A 766.0 0.0 0.0 18,863.0 View
Jul 10, 2026 See Remarks S D 5,945.0 4.172 24,802.54 206,554.0 View
Jun 02, 2026 Principal Accounting Officer S D 265.0 4.43 1,173.95 66,583.0 View
Apr 10, 2026 — A A 3,775.0 0.0 0.0 56,254.0 View
Apr 10, 2026 — A A 3,775.0 0.0 0.0 79,084.0 View
Apr 10, 2026 — A A 1,192.0 0.0 0.0 18,097.0 View